S&P 500
(0.02%) 5 071.63 points
Dow Jones
(-0.11%) 38 461 points
Nasdaq
(0.10%) 15 713 points
Oil
(0.12%) $82.91
Gas
(-0.36%) $1.647
Gold
(-0.58%) $2 324.90
Silver
(-0.90%) $27.10
Platinum
(-0.59%) $910.40
USD/EUR
(-0.07%) $0.934
USD/NOK
(-0.06%) $10.98
USD/GBP
(-0.02%) $0.802
USD/RUB
(-0.02%) $92.30

Realtime updates for Living Cell Technologies [LVCLY]

Exchange: OTC Sector: Healthcare Industry: Biotechnology
Last Updated24 Apr 2024 @ 14:28

-7.22% $ 0.0427

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 14:28):

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand...

Stats
Today's Volume 2 300.00
Average Volume 2 596.00
Market Cap 10.15M
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.27
ATR14 $0 (0.00%)

Living Cell Technologies Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Living Cell Technologies Financials

Annual 2023
Revenue: $42 016.00
Gross Profit: $41 459.00 (98.67 %)
EPS: $-0.00160
Q2 2024
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.000900
Q4 2023
Revenue: $42 016.00
Gross Profit: $42 016.00 (100.00 %)
EPS: $-0.000500
Q3 2022
Revenue: $21 008.00
Gross Profit: $21 008.00 (100.00 %)
EPS: $-0.000300

Financial Reports:

No articles found.

Living Cell Technologies

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators